Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

21.04.18	An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDR…) (RTTNews)
20.04.18	Lilly Reports Additional Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 RANGE Study in Advanced or Metastatic Urothelial Cancer (PR Newswire)
20.04.18	Lilly to Present Phase 3 Data at AAN 2018 Reinforcing Commitment to New, Innovative Therapies in Migraine (PR Newswire)
16.04.18	Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease (PR Newswire)
15.04.18	St. Baldrick's Foundation Commits $8 million to Support Pediatric Cancer Dream Team with Stand Up To Cancer (PR Newswire)
05.04.18	CNAT Disappoints, EBIO To Report VISTA Data In May, PRTK To Face FDA In Oct. (RTTNews)
04.04.18	Lilly Confirms Date and Conference Call for First-Quarter 2018 Financial Results Announcement (PR Newswire)
04.04.18	Eli Lilly, Sigilon Announce Global Collaboration - Quick Facts (RTTNews)
04.04.18	Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes (PR Newswire)
04.04.18	Eli Lilly: CYRAMZA Phase 3 REACH-2 Study Meets Primary Endpoint - Quick Facts (RTTNews)
04.04.18	Lilly Announces CYRAMZA® (ramucirumab) Phase 3 REACH-2 Study in Second-Line Hepatocellular Carcinoma Patients Met Overall Survival Endpoint (PR Newswire)
03.04.18	Improving Cardiology Care: BIOTRONIK US to Distribute Aziyo ECM Envelopes (PR Newswire)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
28.03.18	Biotech Stocks Facing FDA Decision In April (RTTNews)
23.03.18	Un plan audacieux pour le Québec! - Plan d'action gouvernemental en entrepreneuriat (PR Newswire)
09.03.18	Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology (PR Newswire)
08.03.18	EFSD, JDRF, Lilly Extend Collaboration Supporting Type 1 Diabetes Research (RTTNews)
08.03.18	EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research (PR Newswire)
06.03.18	Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials (PR Newswire)
26.02.18	Eli Lilly Announces Additional FDA Approval For Verzenio - Quick Facts (RTTNews)
26.02.18	Lilly Receives Additional FDA Approval for VerzenioTM (abemaciclib), as Initial Treatment for Advanced Breast Cancer (PR Newswire)
26.02.18	Eli Lilly Reports New Data From Trulicity Phase 3b Study - Quick Facts (RTTNews)
26.02.18	New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes (PR Newswire)
21.02.18	Lilly to Participate in Barclays Global Healthcare Conference (PR Newswire)
20.02.18	Lilly to Participate in Cowen Health Care Conference (PR Newswire)
20.02.18	Survey Reveals Many People with Migraine Live with Pain Nearly Half of Every Month (PR Newswire)
19.02.18	Eli Lilly: Taltz Improves Sexual Health Of Genital Psoriasis Patients (RTTNews)
19.02.18	AAD 2018: Treatment with Lilly's Taltz® (ixekizumab) Resulted in Improvement in Impact of Genital Psoriasis on Sexual Activity (PR Newswire)
14.02.18	Lilly to Showcase New Data for Taltz® (ixekizumab) and Other Products Across Immunology Pipeline at AAD Annual Meeting (PR Newswire)
13.02.18	Eli Lilly: Taltz Phase 3 Study Meets Endpoints To Treat Ankylosing Spondylitis (RTTNews)
13.02.18	Lilly Announces Positive Top-Line Phase 3 Results for Taltz® (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis) (PR Newswire)
31.01.18	Lilly Lifts 2018 Profit View; Backs Revenue Outlook (RTTNews)
31.01.18	Eli Lilly And Co. Profit Rises In Q4 (RTTNews)
31.01.18	Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance (PR Newswire)
26.01.18	Lilly To Present At Leerink Partners Global Healthcare Conference (PR Newswire)
26.01.18	Elanco Announces Global Agreement with Ab E Discovery for New Technology (PR Newswire)
22.01.18	Eli Lilly Animal Health Unit Announces FDA Approval Of Credelio - Quick Facts (RTTNews)
22.01.18	Elanco Animal Health Announces U.S. Food and Drug Administration (FDA) Approval of Credelio® (lotilaner) to Treat and Protect Against Ticks and Fleas (PR Newswire)
22.01.18	Some Branded Drugs Going Generic In 2018 (RTTNews)
18.01.18	Elanco Innovations Named Best Products for 2017 (PR Newswire)
18.01.18	GALLIPRANT® (grapiprant tablets) Named Best Companion Animal Product for 2017 (PR Newswire)
15.01.18	Federal-Mogul Motorparts' Abex® Brand Introduces New Brake Rotors for Commercial Vehicle Market (PR Newswire)
11.01.18	Elanco Announces Addition of New North America and Global Strategy Senior Executive (PR Newswire)
11.01.18	Elanco, Aratana Announce Marketing Authorization of GALLIPRANT® (grapiprant tablets) in Europe (PR Newswire)
08.01.18	Livongo and Lilly Collaborate on Real-World Diabetes Research (PR Newswire)
05.01.18	Lilly Confirms Date and Conference Call for Fourth-Quarter 2017 Financial Results Announcement (PR Newswire)
02.01.18	Vancouver Island 2018 Property Assessment Notices in the Mail (PR Newswire)
18.12.17	Lilly to Participate in Goldman Sachs Healthcare CEOs Unscripted Conference (PR Newswire)
14.12.17	Rimidi and Lilly Collaborate to Personalize Solutions for People Using Insulin (PR Newswire)
13.12.17	Lilly Cuts 2017 EPS View; Announces Outlook Through 2020 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09:28		STOXX-Handel Euro STOXX 50 verliert zum Start
09:28		Zurückhaltung in Frankfurt: LUS-DAX beginnt die Sitzung im Minus
09:28		Schwacher Wochentag in Zürich: SMI notiert zum Start im Minus
09:16		Novartis-Aktie etwas leichter: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen - Positive Studienergebnisse zu Gentherapie
27.12.24		Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus
27.12.24		BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
27.12.24		Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge
27.12.24		Freitagshandel in Frankfurt: LUS-DAX zeigt sich letztendlich fester

09:28

STOXX-Handel Euro STOXX 50 verliert zum Start

09:28

Zurückhaltung in Frankfurt: LUS-DAX beginnt die Sitzung im Minus

09:28

Schwacher Wochentag in Zürich: SMI notiert zum Start im Minus

09:16

Novartis-Aktie etwas leichter: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen - Positive Studienergebnisse zu Gentherapie

27.12.24

Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus

27.12.24

BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester

27.12.24

Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

27.12.24

Freitagshandel in Frankfurt: LUS-DAX zeigt sich letztendlich fester

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	137.80	0.33 %	K V
Nestle	74.64	0.30 %	K V
Kuehne+Nagel Int	207.80	0.14 %	K V
Swiss Life Hldg	698.40	0.14 %	K V
Swisscom	502.50	-0.10 %	K V
Zurich Insur Gr	537.60	-0.37 %	K V
Swiss Re	131.10	-0.42 %	K V
Sika	215.60	-0.46 %	K V
Logitech Intl	74.70	-0.51 %	K V
ABB	49.15	-0.79 %	K V

Nachrichten zu Eli Lilly

Aktien Top/Flop

Eli Lilly Peer Group Nachrichten

Meistgelesene Nachrichten